ZYME Stock Overview – The Average Joe

Newsletter

Latest Issues Subscribe

Company

About Us Jobs
NYSE:ZYME

Loading...

Market cap

$Loading...

Sector

Loading...

Dividend Yield

Loading...

52-week range

Loading... Loading...

Expected earnings date

August 8, 2024

Description

Loading...

Returns 1M 6M 1Y 5Y 10Y
$ZYME N/A N/A N/A N/A N/A
S&P500 N/A N/A N/A N/A N/A
Valuation P/E Ratio (TTM) P/S Ratio (TTM)
Zymeworks Inc. Loading... Loading...
Sector Name Loading... N/A

Related

DAWNDay One Biopharmaceuticals, Inc.11.3%
INZYInozyme Pharma, Inc.-4.3%
ZNTLZentalis Pharmaceuticals, Inc.-50.7%
SNDXSyndax Pharmaceuticals, Inc.-4.1%
PTGXProtagonist Therapeutics, Inc.0.4%

Analyst Ratings

Buy Loading...
Hold Loading...
Sell Loading...

Financial Overview

FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023
Revenue2M10M11M52M53M30M39M27M412M76M
Growth Rate-478.4%14.0%370.2%2.4%-44.3%31.8%-31.5%1,446.0%-81.6%
EBITDA-13M-19M-36M-6M-33M-150M-187M-216M131M-120M
EBITDA Margin-749.3%-198.2%-329.4%-11.4%-62.5%-506.9%-481.3%-808.2%31.6%-157.2%
Net Income-13M-19M-34M-10M-37M-145M-181M-212M124M-119M
NI Margin-775.0%-198.4%-307.1%-20.1%-68.9%-492.3%-463.5%-794.0%30.1%-156.1%
×

Become a better investor with our free daily newsletters

Join 250,000+ investors discovering new market trends and ideas.